Site-Overview.com
 

Analysis of websites containing pi.amgen.com backlinks

These websites are/were linking to pi.amgen.com.

 
Websites found: 21
Number of websited displayed: 21
 

List of results:

Manage My Co-pay
http://site-overview.com/stats/managemycopay.com
Manage My Co-pay; Amgen managemycopay;
  • Website Address renewal date: 17/1/29
  • Domain Address Reg. date: 15/9/12
  • Website address in use until: 20/9/12
NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating Factor
http://site-overview.com/stats/neupogenhcp.com
Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.
  • Website Address renewal date: 17/11/12
  • Domain Address Reg. date: 12/12/14
  • Website address in use until: 18/12/14
Neulasta® (pegfilgrastim) | G-CSF Injection
http://site-overview.com/stats/neulasta.com
Learn about Neulasta® (pegfilgrastim) and Neulasta® Onpro™, the on-body injector designed to administer Neulasta®.
  • Website Address renewal date: 16/12/10
  • Domain Address Reg. date: 02/1/11
  • Website address in use until: 18/1/11
KYPROLIS® (carfilzomib) for Relapsed Multiple Myeloma Treatment
http://site-overview.com/stats/kyprolis.com
KYPROLIS® (carfilzomib) is a treatment option for people who have already received 1 or more previous treatments for relapsed multiple myeloma. Learn how KYPROLIS may help.
  • Website Address renewal date: 15/11/10
  • Domain Address Reg. date: 10/5/11
  • Website address in use until: 17/5/11
Repatha® (evolocumab) Official HCP Site | Repatha® (evolocumab)
http://site-overview.com/stats/repathahcp.com
Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.
  • Website Address renewal date: 18/1/3
  • Domain Address Reg. date: 15/2/4
  • Website address in use until: 23/2/4
EPOGEN® treatment for patients with anemia due to chronic kidney disease (CKD) | EPOGEN® (epoetin alfa)
http://site-overview.com/stats/epogen.com
EPOGEN® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis to reduce or avoid the need for red blood cell transfusions.
  • Website Address renewal date: 17/4/25
  • Domain Address Reg. date: 98/5/28
  • Website address in use until: 18/5/27
Welcome to Amgen
http://site-overview.com/stats/amgenfirststep.com
  • Website Address renewal date: 17/9/21
  • Domain Address Reg. date: 10/10/22
  • Website address in use until: 18/10/22
High Cholesterol Treatment | Lower LDL | Repatha® (evolocumab)
http://site-overview.com/stats/repatha.com
Repatha® (evolocumab) is used along with diet & maximally tolerated statin for high LDL cholesterol.
  • Website Address renewal date: 16/10/21
  • Domain Address Reg. date: 13/11/22
  • Website address in use until: 17/11/22
Chronic Heart Failure | Corlanor® (ivabradine) Official Site
http://site-overview.com/stats/corlanor.com
Corlanor® (ivabradine) is a chronic heart failure treatment. Learn about Chronic HF symptoms and causes. Get the complete details on Corlanor® benefits and safety.
  • Website Address renewal date: 17/2/1
  • Domain Address Reg. date: 09/3/5
  • Website address in use until: 19/3/5
For the Treatment of Postmenopausal Osteoporosis Women at High Risk for Fracture | Prolia® (denosumab)
http://site-overview.com/stats/prolia.com
Learn how Prolia® (denosumab) can help in the treatment of postmenopausal osteoporosis for women at high risk for fracture.
  • Website Address renewal date: 16/8/7
  • Domain Address Reg. date: 99/9/8
  • Website address in use until: 17/9/8
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCP
http://site-overview.com/stats/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
  • Website Address renewal date: 17/9/3
  • Domain Address Reg. date: 05/10/5
  • Website address in use until: 18/10/5
Enbrel® (etanercept) - ¡Próximamente!
http://site-overview.com/stats/enbrelenespanol.com
Use the Enbrel® (etanercept) site map to find the page you're looking for on Enbrel.com.
  • Website Address renewal date: 17/5/25
  • Domain Address Reg. date: 06/6/26
  • Website address in use until: 18/6/26
aranesp.com
http://site-overview.com/stats/aranesp.com
  • Website Address renewal date: 16/8/12
  • Domain Address Reg. date: 99/9/13
  • Website address in use until: 17/9/13
Parsabiv™ (etelcalcetide)
http://site-overview.com/stats/parsabiv.com
  • Website Address renewal date: 17/11/7
  • Domain Address Reg. date: 14/12/9
  • Website address in use until: 18/12/9
ITP Treatment - ITP (immune thrombocytopenia) & Nplate® (romiplostim)
http://site-overview.com/stats/nplate.com
Nplate® (romiplostim) - The Official Site - Learn more about ITP (immune thrombocytopenia) and Nplate®, a treatment for adults with chronic ITP.
  • Website Address renewal date: 16/12/11
  • Domain Address Reg. date: 08/1/12
  • Website address in use until: 18/1/12
Patients with Bone Metastases from Solid Tumors | XGEVA® (denosumab)
http://site-overview.com/stats/xgeva.com
Learn more about preventing serious bone problems with XGEVA® (denosumab) injections.
  • Website Address renewal date: 16/5/6
  • Domain Address Reg. date: 10/6/7
  • Website address in use until: 17/6/7
www.sensiparhcp.com
http://site-overview.com/stats/sensiparhcp.com
  • Website Address renewal date: 12/4/10
  • Domain Address Reg. date: 09/5/13
  • Website address in use until: 19/5/13
Enbrel® (etanercept)
http://site-overview.com/stats/enbrel.com
Enbrel® (etanercept) is a prescription medicine used to treat five chronic diseases, including moderate to severe plaque psoriasis and rheumatoid arthritis.
  • Google Analytics ID: 70400828-1
  • Website Address renewal date: 17/1/10
  • Domain Address Reg. date: 99/2/11
  • Website address in use until: 18/2/11
IMLYGIC® (talimogene laherparepvec) Oncolytic Viral Therapy
http://site-overview.com/stats/imlygic.com
Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.
  • Website Address renewal date: 17/2/25
  • Domain Address Reg. date: 12/3/29
  • Website address in use until: 18/3/29
Amgen UA
http://site-overview.com/stats/amgenual.com
  • Website Address renewal date: 16/5/26
  • Domain Address Reg. date: 16/5/26
  • Website address in use until: 18/5/26
KYPROLIS® (carfilzomib) for HCPs | Relapsed or Refractory Multiple Myeloma Treatment
http://site-overview.com/stats/kyprolis-hcp.com
Learn about clinical trial data for KYPROLIS® (carfilzomib)—treats relapsed or refractory multiple myeloma.
  • Website Address renewal date: 17/9/17
  • Domain Address Reg. date: 15/10/19
  • Website address in use until: 18/10/19
2024-05-02 02:22:22 ... 0.0225